Main Street Research’s Ambev ABEV Stock Holding History

Main Street Research’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-17,182	Closed	-$48K	–	117
2021 Q4	$48K	Hold	17,182	–	–	﹤0.01%	140
2021 Q3	$47K	Buy	+17,182	New	+$54.4K	﹤0.01%	137
2014 Q1	–	Sell	-321,195	Closed	-$2.36M	–	138
2013 Q4	$2.36M	Buy	+321,195	New	+$2.35M	0.59%	65

Other funds holding ABEV

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $625M AUM 21.08% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.68B AUM 76.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Main Street Research's ABEV Position: Q1 2022 in Review

Main Street Research sold out of Ambev (ABEV) in Q1 2022, closing a stake of 17,182 shares — an estimated $48K sold.

Main Street Research first reported a position in ABEV in Q4 2013 and held it in 3 quarters. The position peaked at $2.36M in Q4 2013. 287 funds tracked by Wall St. Rank hold ABEV as of Q1 2022.

Main Street Research reported no remaining Ambev position as of Q1 2022 after selling out during the quarter.
Main Street Research sold 17,182 Ambev shares in Q1 2022, an estimated $48K.
Main Street Research first reported a position in Ambev in Q4 2013 and held it in 3 quarters.
Main Street Research's Ambev position peaked at $2.36M in Q4 2013.
287 funds tracked by Wall St. Rank held Ambev as of Q1 2022.

Based on Main Street Research's 13F filing for Q1 2022, filed 5 May 2022.